DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Zinman B, Wanner C, Lachin JM. et al
Empagliflozin, cardiovascular outcomes and mortality in type 2 diabetes.
N Engl J Med 2015;
373: 2117-2128 . doi:10.1056/NEJMoa1504720
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.